These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

520 related items for PubMed ID: 30064061

  • 1. Initial results of a drug checking pilot program to detect fentanyl adulteration in a Canadian setting.
    Tupper KW, McCrae K, Garber I, Lysyshyn M, Wood E.
    Drug Alcohol Depend; 2018 Sep 01; 190():242-245. PubMed ID: 30064061
    [Abstract] [Full Text] [Related]

  • 2. Drug checking as a potential strategic overdose response in the fentanyl era.
    Laing MK, Tupper KW, Fairbairn N.
    Int J Drug Policy; 2018 Dec 01; 62():59-66. PubMed ID: 30359874
    [Abstract] [Full Text] [Related]

  • 3. Take-home drug checking as a novel harm reduction strategy in British Columbia, Canada.
    Klaire S, Janssen RM, Olson K, Bridgeman J, Korol EE, Chu T, Ghafari C, Sabeti S, Buxton JA, Lysyshyn M.
    Int J Drug Policy; 2022 Aug 01; 106():103741. PubMed ID: 35671687
    [Abstract] [Full Text] [Related]

  • 4. Drug checking services at music festivals and events in a Canadian setting.
    McCrae K, Tobias S, Tupper K, Arredondo J, Henry B, Mema S, Wood E, Ti L.
    Drug Alcohol Depend; 2019 Dec 01; 205():107589. PubMed ID: 31605958
    [Abstract] [Full Text] [Related]

  • 5. A new quantitative drug checking technology for harm reduction: Pilot study in Vancouver, Canada using paper spray mass spectrometry.
    Borden SA, Saatchi A, Vandergrift GW, Palaty J, Lysyshyn M, Gill CG.
    Drug Alcohol Rev; 2022 Feb 01; 41(2):410-418. PubMed ID: 34347332
    [Abstract] [Full Text] [Related]

  • 6. Detecting fentanyl using point-of-care drug checking technologies: A validation study.
    Ti L, Tobias S, Lysyshyn M, Laing R, Nosova E, Choi J, Arredondo J, McCrae K, Tupper K, Wood E.
    Drug Alcohol Depend; 2020 Jul 01; 212():108006. PubMed ID: 32438280
    [Abstract] [Full Text] [Related]

  • 7. Fentanyl and heroin contained in seized illicit drugs and overdose-related deaths in British Columbia, Canada: An observational analysis.
    Baldwin N, Gray R, Goel A, Wood E, Buxton JA, Rieb LM.
    Drug Alcohol Depend; 2018 Apr 01; 185():322-327. PubMed ID: 29486421
    [Abstract] [Full Text] [Related]

  • 8. Results from a mobile drug checking pilot program using three technologies in Chicago, IL, USA.
    Karch L, Tobias S, Schmidt C, Doe-Simkins M, Carter N, Salisbury-Afshar E, Carlberg-Racich S.
    Drug Alcohol Depend; 2021 Nov 01; 228():108976. PubMed ID: 34536717
    [Abstract] [Full Text] [Related]

  • 9. Evaluation of a fentanyl drug checking service for clients of a supervised injection facility, Vancouver, Canada.
    Karamouzian M, Dohoo C, Forsting S, McNeil R, Kerr T, Lysyshyn M.
    Harm Reduct J; 2018 Sep 10; 15(1):46. PubMed ID: 30200991
    [Abstract] [Full Text] [Related]

  • 10. Acceptability of implementing community-based drug checking services for people who use drugs in three United States cities: Baltimore, Boston and Providence.
    Sherman SG, Morales KB, Park JN, McKenzie M, Marshall BDL, Green TC.
    Int J Drug Policy; 2019 Jun 10; 68():46-53. PubMed ID: 30991301
    [Abstract] [Full Text] [Related]

  • 11. Effect of witnessing an overdose on the use of drug checking services among people who use illicit drugs in Vancouver, Canada.
    Beaulieu T, Hayashi K, Nosova E, Milloy MJ, DeBeck K, Wood E, Kerr T, Ti L.
    Am J Drug Alcohol Abuse; 2020 Jul 03; 46(4):506-511. PubMed ID: 31983241
    [Abstract] [Full Text] [Related]

  • 12. Examining fentanyl and its analogues in the unregulated drug supply of British Columbia, Canada using drug checking technologies.
    Crepeault H, Socias ME, Tobias S, Lysyshyn M, Custance A, Shapiro A, Ti L.
    Drug Alcohol Rev; 2023 Mar 03; 42(3):538-543. PubMed ID: 36423900
    [Abstract] [Full Text] [Related]

  • 13. High willingness to use rapid fentanyl test strips among young adults who use drugs.
    Krieger MS, Yedinak JL, Buxton JA, Lysyshyn M, Bernstein E, Rich JD, Green TC, Hadland SE, Marshall BDL.
    Harm Reduct J; 2018 Feb 08; 15(1):7. PubMed ID: 29422052
    [Abstract] [Full Text] [Related]

  • 14. Motivators of and barriers to drug checking engagement in British Columbia, Canada: Findings from a cross-sectional study.
    Tobias S, Ferguson M, Palis H, Burmeister C, McDougall J, Liu L, Graham B, Ti L, Buxton JA.
    Int J Drug Policy; 2024 Jan 08; 123():104290. PubMed ID: 38101275
    [Abstract] [Full Text] [Related]

  • 15. High concentrations of illicit stimulants and cutting agents cause false positives on fentanyl test strips.
    Lockwood TE, Vervoordt A, Lieberman M.
    Harm Reduct J; 2021 Mar 09; 18(1):30. PubMed ID: 33750405
    [Abstract] [Full Text] [Related]

  • 16. Fentanyl Concentration in Drug Checking Samples and Risk of Overdose Death in Vancouver, Canada.
    Kennedy MC, Dong H, Tobias S, Buxton JA, Lysyshyn M, Tupper KW, Ti L.
    Am J Prev Med; 2024 Jan 09; 66(1):10-17. PubMed ID: 37633426
    [Abstract] [Full Text] [Related]

  • 17. Current attitudes toward drug checking services and a comparison of expected with actual drugs present in street drug samples collected from opioid users.
    Swartz JA, Lieberman M, Jimenez AD, Mackesy-Amiti ME, Whitehead HD, Hayes KL, Taylor L, Prete E.
    Harm Reduct J; 2023 Jul 07; 20(1):87. PubMed ID: 37420196
    [Abstract] [Full Text] [Related]

  • 18. Distribution of take-home opioid antagonist kits during a synthetic opioid epidemic in British Columbia, Canada: a modelling study.
    Irvine MA, Buxton JA, Otterstatter M, Balshaw R, Gustafson R, Tyndall M, Kendall P, Kerr T, Gilbert M, Coombs D.
    Lancet Public Health; 2018 May 07; 3(5):e218-e225. PubMed ID: 29678561
    [Abstract] [Full Text] [Related]

  • 19. Assessing the limit of detection of Fourier-transform infrared spectroscopy and immunoassay strips for fentanyl in a real-world setting.
    McCrae K, Tobias S, Grant C, Lysyshyn M, Laing R, Wood E, Ti L.
    Drug Alcohol Rev; 2020 Jan 07; 39(1):98-102. PubMed ID: 31746056
    [Abstract] [Full Text] [Related]

  • 20. An outbreak of novel psychoactive substance benzodiazepines in the unregulated drug supply: Preliminary results from a community drug checking program using point-of-care and confirmatory methods.
    Laing MK, Ti L, Marmel A, Tobias S, Shapiro AM, Laing R, Lysyshyn M, Socías ME.
    Int J Drug Policy; 2021 Jul 07; 93():103169. PubMed ID: 33627302
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.